Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
Once perceived as a disorder treated by vasodilation, pulmonary artery hypertension (PAH) has emerged as a pulmonary vascular disease with severe endothelial cell dysfunction. In the absence of a cure, many studies seek to understand the detailed mechanisms of EC regulation to potentially create mor...
Guardado en:
Autores principales: | Jaylen Hudson, Laszlo Farkas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d9b3eba1f3641329b062bb9c812a124 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Niveles aumentados de estrés oxidativo se asocian a disfunción endotelial periférica y respuesta vascular pulmonar disminuida frente a vasodilatadores en pacientes con hipertensión pulmonar
por: Gabrielli,Luigi, et al.
Publicado: (2010) -
Role of immunological disorders, endothelial dysfunction and hemostatic disorders in the genesis of arterial hypertension in the metabolic syndrome
por: E. I. Polozova, et al.
Publicado: (2020) -
Levels of endothelial substances in patients with newly identified hypertension compared with healthy controls
por: Vladislav Biel, et al.
Publicado: (2021) -
Serum levels of endothelial monocyte activating polypeptide-II in type 1 diabetes patients with microangyopathy and arterial hypertention.
por: Liliya A. Mogylnytska, et al.
Publicado: (2016) -
Incremental Experience in In Vitro Primary Culture of Human Pulmonary Arterial Endothelial Cells Harvested from <i>Swan-Ganz</i> Pulmonary Arterial Catheters
por: Birger Tielemans, et al.
Publicado: (2021)